Read the full press release here Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Aldevron, LLC, the leading provider of high-quality plasmid DNA, mRNA and recombinant proteins necessary for vaccines, gene and cell therapy, gene editing and diagnostic applications, have announced their expanded collaboration in support of the Moderna COVID-19 Vaccine […]

Read the full press release here NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, and Clarity Pharmaceuticals, a clinical stage radiopharmaceutical company focused on the treatment of serious disease, today announced the signing of a Master Supply Agreement for the therapeutic […]

Read the full press release here An analysis of electronic health records for 1.7 million Wisconsin patients revealed a variety of health problems newly associated with fragile X syndrome, the most common inherited cause of intellectual disability and autism, and may help identify cases years in advance of the typical clinical diagnosis. Researchers from the […]

Read the full press release here  Vivid Microscopy, an emerging biotech company in the United States, today announced the production of a high content screening probe that can image and sort cells based on the levels of thiol-based oxidative stress. This probe, SEMKUR-IM, utilizes florescent technology to identify cell injury without damaging tissue samples. Demonstrated […]

Read the full press release here The United States Preventive Services Task Force (USPSTF) today released its final colorectal cancer screening recommendation that screening begin at age 45. Exact Sciences’ Cologuard®, referred to as sDNA-FIT, is included as a recommended screening option for all average-risk patients between the ages of 45 and 75. Colorectal cancer is the […]

Read the full press release here OncoTEX Inc, an oncology company, and member of the iQ Group Global bioscience investment enterprise The iQ Group Global and Sterling Pharma Solutions, a global contract development and manufacturing organisation, have signed a clinical development agreement for the manufacture of OncoTex’s novel platinum-resistant oncology drug candidate, OxaliTEX, for use in clinical […]

Read the full press release here Eurofins Technologies continues to develop a range of diagnostic solutions for COVID-19, particularly in response to the threat of emerging mutations. Today, we announce the launch of two new products: GSD NovaPrime® Plus SARS-CoV-2, a PCR test which can detect, in one reaction, key mutations of variants of concern, present […]

BioForward recently welcomed Mohammed Soumaoro aboard as its membership experience and program coordinator. Soumaoro will support BioForward’s membership activities through improving membership experience and communications, supporting the purchasing consortium administration, internal project management, assisting with member events, and providing executive support to the CEO. “We are thrilled that Mohammed has joined our BioForward team,” CEO […]